Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Cystic FibrosisExocrine Pancreatic InsufficiencyPancreatic DiseasesDigestive System Diseases
Interventions
DRUG

Pancrelipase

Trial Locations (21)

462-8508

Site Reference ID/Investigator# 73813, Aichi

466-8650

Site reference ID/Investigator # 96698, Aichi

467-8602

Research facility ID ORG-000141, Aichi

470-0224

Site reference ID/Investigator no. ORG-000842, Aichi

474-8710

Site reference ID/Investigator # 93736, Aichi

794-0006

Research facility ORG-000972, Ehime

660-8550

Mylan investigational site A, Hyōgo

305-8520

Site reference ID/Investigator # 93735, Ibaraki

305-8558

Site Reference ID/Investigator# 88673, Ibaraki

920-8641

Site Reference ID/Investigator# 65529, Ishikawa

760-0017

Site Reference ID/Investigator# 65530, Kagawa

890-8520

Site Reference ID/Investigator# 65527, Kagoshima

232-8555

Mylan investigational site C, Kanagawa

980-0872

Site Reference ID/Investigator# 65528, Miyagi

989-3126

Mylan investigational site B, Miyagi

534-0021

Research facility ID ORG-000594, Osaka

874-0011

Research facility ID ORG-001138, Ōita

438-8550

Research facility ORG-000971, Shizuoka

329-0431

Site reference ID/Investigator# 117495, Tochigi

108-8329

Research facility no. ORG-001309, Tokyo

157-8535

Site Reference ID/Investigator# 67122, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mylan Inc.

INDUSTRY